Stock Alert: Larimar Therapeutics Down 14%

Shares of Larimar Therapeutics, Inc. (LRMR) are slipping nearly 14% on Tuesday morning. The clinical-stage biotechnology company focused on rare diseases reported positive data from early stage study of CTI-1601 as a treatment for Friedreich’s Ataxia. LRMR is currently trading at $11.29, down $1.83 or 13.95%, on the Nasdaq. Friedreich […]

» Read more

Stock Alert: Kodiak Sciences Down 15%

Shares of Kodiak Sciences Inc. (KOD) are currently losing nearly 15% on Monday morning after reporting its first-quarter results. KOD is currently trading at $87.10, down $14.52 or 14.29%, on the Nasdaq. Kodiak reported net loss for the first quarter of $50.4 million or $0.98 per share, as compared to […]

» Read more
1 124 125 126 127 128 169